Gradalis® — Immunotherapy

Gradalis is developing Vigil®, a fully personalized, patient-specific cancer immunotherapy with potential applications across multiple solid tumor types including ovarian cancer.

Vigil is currently for people with

Ovarian cancer ↗︎

About Gradalis

Find out more about who we are, our leadership, and our board of directors

About Vigil

Discover how Vigil fights cancer through our unique process

Careers

We hire the best, and offer one of the best benefits packages available

See how we can help